• Integral Molecular Awarded $1.4 Million by NIH americanpharmaceuticalreview
    December 05, 2018
    Integral Molecular was awarded $1.4M by the NIH to develop its lead antibodies against cannabinoid receptor 1 (CB1) for treating the liver disease nonalcoholic.....
PharmaSources Customer Service